Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has generated a worldwide pandemic. The interruption of its spread depends on a combination of pharmacologic and nonpharmacologic interventions. Initial SARS-CoV-2 prevention incl...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 383; no. 6; pp. 585 - 586
Main Author Cohen, Myron S
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 06.08.2020
Subjects
Betacoronavirus
Chloroquine
Coronaviridae
Coronavirus Infections - prevention & control
Coronaviruses
COVID-19
Environmental hygiene
Humans
Hydroxychloroquine
Hygiene
Infections
Pandemics
Pneumonia, Viral - prevention & control
Prevention
Prophylaxis
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Online AccessGet full text

Cover

More Information
Summary:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has generated a worldwide pandemic. The interruption of its spread depends on a combination of pharmacologic and nonpharmacologic interventions. Initial SARS-CoV-2 prevention includes social distancing, the use of face masks, environmental hygiene, and hand washing. 1 Although the most important pharmacologic interventions to prevent SARS-CoV-2 infection are likely to be vaccines, the repurposing of established drugs for short-term prophylaxis is another, more immediate option. Some researchers have promoted chloroquine and hydroxychloroquine for the treatment and prevention of illness from a variety of microorganisms, including SARS-CoV. 2 Hydroxychloroquine . . .
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMe2020388